| Model Number |
N/A |
| Medical Device Problem Code |
False Negative Result (1225)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
07/23/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An outside the united states customer observed a discordant hepatitis c (ahcv) negative patient result for a patient using the atellica im 1600 analyzer.The result was positive when tested by an alternate method.Quality control material was not tested.The interpretation of results section of the instructions for use states: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." the limitations section of the instructions for use states: "a negative test result does not exclude the possibility of exposure to or infection with hcv.Hcv antibodies may be undetectable in some stages of the infection and in some clinical conditions." siemens is investigating.
|
| |
|
Event or Problem Description
|
|
The customer observed a discordant hepatitis c (ahcv) negative patient result for a patient using the atellica im 1600 analyzer.The result was positive when tested by an alternate method.The atellica im ahcv result was not reported to the physician.There are no reports that treatment was altered or prescribed or adverse health consequences due to the negative ahcv result.
|
| |
|
Additional Manufacturer Narrative
|
|
The initial mdr 1219913-2022-00299 was filed on october 3, 2022.Additional information - october 25, 2022: siemens has completed the investigation into the report from a customer outside the united states regarding a discordant negative hcv result on a patient run on atellica im hepatitis c (hcv) kit lot 418.The sample reported positive on an alternate method- as well as western blot.The sample was not available to be tested in house.Based on the blot results the sample should have been considered indeterminate.As per the instructions for use for the blot test, an indeterminate result should not be used as a basis for diagnosis of hcv infection.Reactivity of >_1+ on one hcv antigen only may be non specific reactivity, an indication of past resolved infection, or an indication of early seroconversion.The further recommendation is retesting the patient 2-6 months later.In review of everything presented, it is possible this sample is from a patient with a very old infection that the blot also can not determine on the sample.It would be beneficial to know when the patient was diagnosed and treated to determine how old the potential infection was however this information was not provided.Siemens' recommendation is to discuss the interpretation of the blot results and to review sensitivity and specificity in the atellica im hcv ifu as compared to the customer data.The customer has not reported further discrepancies.The system is running as intended.No product non conformance was identified.In section h6, the investigation finding, and investigation conclusion codes were updated.
|
| |
|
Search Alerts/Recalls
|